Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human oral cavity, blood and human faeces
DNA G+C(%): 52
|
Bile reaction(%): 20(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amp-sulb: S(MIC50): 0.5, MIC90: 1, RNG: (0.03–2)
piper-taz: S(MIC50): 0.03, MIC90: 0.03, RNG: (0.03–0.25)
imipenem: S(MIC50): 0.06, MIC90: 0.125, RNG: (0.03–0.125)
|
|
|
|
moxifloxacin: S(MIC50): 2, MIC90: 4, RNG: (0.25–4)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tigecycline: S(MIC50): 0.5, MIC90: 0.5, RNG: (0.03–1)
|
|
|
metronidazole: S(MIC50): 0.5, MIC90: 1, RNG: (0.25–2)
|
clindamycin: R(MIC50): 0.03, MIC90: >32, RNG: (0.03->32)
|